{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:24:02Z","timestamp":1779193442264,"version":"3.51.4"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/bor.0b013e3283585748","type":"journal-article","created":{"date-parts":[[2012,8,18]],"date-time":"2012-08-18T17:24:43Z","timestamp":1345310683000},"page":"597-601","source":"Crossref","is-referenced-by-count":22,"title":["Skin disease in dermatomyositis"],"prefix":"10.1097","volume":"24","author":[{"given":"Lisa C.","family":"Zaba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210128","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jaad.2010.10.016","article-title":"Quality of life in dermatomyositis.","volume":"65","author":"Goreshi","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R2-3-20210128","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1002\/art.27529","article-title":"Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells.","volume":"62","author":"Shrestha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R3-3-20210128","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-2230.2009.03297.x","article-title":"Identification of granzyme B-expressing CD-8-positive T cells in lymphocytic inflammatory infiltrate in cutaneous lupus erythematosus and in dermatomyositis.","volume":"34","author":"Grassi","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"R4-3-20210128","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2230.2010.03808.x","article-title":"The FasFas ligand system, rather than granzyme B, may represent the main mediator of epidermal apoptosis in dermatomyositis.","volume":"35","author":"Torchia","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"R5-3-20210128","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jaut.2010.07.006","article-title":"Characterization of regulatory T cells in patients with dermatomyositis.","volume":"35","author":"Antiga","year":"2010","journal-title":"J Autoimmun"},{"key":"R6-3-20210128","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1600-0560.2009.01443.x","article-title":"The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis.","volume":"37","author":"Magro","year":"2010","journal-title":"J Cutan Pathol"},{"key":"R7-3-20210128","doi-asserted-by":"crossref","first-page":"e29161","DOI":"10.1371\/journal.pone.0029161","article-title":"Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases.","volume":"7","author":"Wong","year":"2012","journal-title":"PloS one"},{"key":"R8-3-20210128","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1186\/ar3549","article-title":"Tumor necrosis factor alpha release in peripheral blood mononuclear cells of cutaneous lupus and dermatomyositis patients.","volume":"14","author":"Nabatian","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"R9-3-20210128","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/jid.2010.244","article-title":"Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNlambda) in cutaneous lupus erythematosus.","volume":"131","author":"Zahn","year":"2011","journal-title":"J Invest Dermatol"},{"key":"R10-3-20210128","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1369\/0022155411411304","article-title":"Identification of specific chondroitin sulfate species in cutaneous autoimmune disease.","volume":"59","author":"Kim","year":"2011","journal-title":"J Histochem Cytochem"},{"key":"R11-3-20210128","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbrc.2012.01.052","article-title":"The role of angiopoietin-like protein 2 in pathogenesis of dermatomyositis.","volume":"418","author":"Ogata","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"R12-3-20210128","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/jid.2012.54","article-title":"Gottrons papules exhibit dermal accumulation of CD44 Variant 7 (CD44v7) and its binding partner osteopontin: a unique molecular signature.","volume":"132","author":"Kim","year":"2012","journal-title":"J Invest Dermatol"},{"key":"R13-3-20210128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archdermatol.2009.328","article-title":"Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota.","volume":"146","author":"Bendewald","year":"2010","journal-title":"Arch Dermatol"},{"key":"R14-3-20210128","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/s10165-010-0362-y","article-title":"Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis.","volume":"21","author":"Azuma","year":"2011","journal-title":"Mod Rheumatol"},{"key":"R15-3-20210128","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1016\/j.jaad.2011.05.044","article-title":"Juvenile dermatomyositis presenting as an acquired inflammatory Blaschko-linear dermatosis.","volume":"65","author":"Lofgren","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R16-3-20210128","first-page":"425","article-title":"A case of juvenile dermatomyositis manifesting inflammatory epidermal nevus-like skin lesions: unrecognized cutaneous manifestation of blaschkitis Allergol I","volume":"59","author":"Takahashi","year":"2010","journal-title":"nt"},{"key":"R17-3-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","article-title":"The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study.","volume":"65","author":"Fiorentino","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R19-3-20210128","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1346-8138.2011.01262.x","article-title":"Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients.","volume":"38","author":"Ikeda","year":"2011","journal-title":"J Dermatol"},{"key":"R20-3-20210128","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar3822","article-title":"Anti-MJNXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositisdermatomyositis.","volume":"14","author":"Ceribelli","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"R21-3-20210128","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/art.24547","article-title":"Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.","volume":"60","author":"Gunawardena","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R22-3-20210128","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archdermatol.2010.134","article-title":"Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations.","volume":"146","author":"Morganroth","year":"2010","journal-title":"Arch Dermatol"},{"key":"R23-3-20210128","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3899\/jrheum.101002","article-title":"Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan.","volume":"38","author":"Yamasaki","year":"2011","journal-title":"J Rheumatol"},{"key":"R24-3-20210128","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/jid.2011.440","article-title":"Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM.","volume":"132","author":"Goreshi","year":"2012","journal-title":"J Invest Dermatol"},{"key":"R25-3-20210128","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/rheumatology\/keq430","article-title":"Association between nail-fold capillary findings and disease activity in dermatomyositis.","volume":"50","author":"Mugii","year":"2011","journal-title":"Rheumatology"},{"key":"R26-3-20210128","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/art.27379","article-title":"Association of normal nailfold end row loop numbers with a shorter duration of untreated disease in children with juvenile dermatomyositis.","volume":"62","author":"Ostrowski","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R27-3-20210128","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/rheumatology\/keq407","article-title":"Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis.","volume":"50","author":"Schmeling","year":"2011","journal-title":"Rheumatology"},{"key":"R28-3-20210128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2230.2011.04188.x","article-title":"Efficacy of low-dose methotrexate in the treatment of dermatomyositis skin lesions.","volume":"37","author":"Hornung","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"R29-3-20210128","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/acr.20269","article-title":"Mycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis.","volume":"62","author":"Rouster-Stevens","year":"2010","journal-title":"Arthritis Care Res"},{"key":"R30-3-20210128","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00296-010-1653-5","article-title":"Mycophenolate mofetil in juvenile dermatomyositis: a case series.","volume":"32","author":"Dagher","year":"2012","journal-title":"Rheumatol Int"},{"key":"R31-3-20210128","first-page":"397","article-title":"The effect of intravenous immunoglobulin (IVIG) treatment on patients with dermatomyositis: a 4-year follow-up study.","volume":"30","author":"Kampylafka","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"R32-3-20210128","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3899\/jrheum.101321","article-title":"Safety and efficacy of rituximab in severe juvenile dermatomyositis: results from 9 patients from the French autoimmunity and rituximab registry.","volume":"38","author":"Bader-Meunier","year":"2011","journal-title":"J Rheumatol"},{"key":"R33-3-20210128","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.22477","article-title":"A randomized, pilot trial of etanercept in dermatomyositis.","volume":"70","author":"Amato","year":"2011","journal-title":"Ann Neurol"},{"key":"R34-3-20210128","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/archdermatol.2011.2052","article-title":"Calcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78 patients, 1996-2009.","volume":"148","author":"Balin","year":"2012","journal-title":"Arch Dermatology"},{"key":"R35-3-20210128","first-page":"135","article-title":"Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis.","volume":"28","author":"Marco Puche","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"R36-3-20210128","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00774-011-0289-1","article-title":"Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy.","volume":"30","author":"Mori","year":"2012","journal-title":"J Bone Miner Metab"},{"key":"R37-3-20210128","first-page":"538","article-title":"Multicenter analysis of calcinosis in children with juvenile dermatomyositis.","volume":"43","author":"Miyamae","year":"2003","journal-title":"Ryumachi"},{"key":"R38-3-20210128","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jpeds.2011.11.057","article-title":"Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis.","volume":"160","author":"Arabshahi","year":"2012","journal-title":"J Pediatr"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0b013e3283585748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:04:17Z","timestamp":1620947057000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201211000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e3283585748","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}